Acepodia Inc

NEW
ROCO:6976 (Taiwan)  
NT$ 12.6 +0.10 (+0.8%) Jul 27
At Loss
P/B:
1.35
Market Cap:
NT$ 7.34B ($ 226.42M)
Enterprise V:
NT$ 3.80B ($ 117.19M)
Volume:
96.61K
Avg Vol (2M):
648.28K
Trade In:
Volume:
96.61K
At Loss
Avg Vol (2M):
648.28K

Business Description

Description
Acepodia Inc is a clinical stage biotechnology company engaged to develop first-in-class cell therapies by using the Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.
Name Current Vs Industry Vs History
Cash-To-Debt
14.6
Equity-to-Asset
0.93
Debt-to-Equity
0.05
Debt-to-EBITDA
-0.41
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
9.64
Distress
Grey
Safe
Beneish M-Score
15.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
66.8
3-Year EPS without NRI Growth Rate
65.2
3-Year FCF Growth Rate
45.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
27.48
9-Day RSI
34.18
14-Day RSI
40.86
3-1 Month Momentum %
0.39
6-1 Month Momentum %
-8.45
12-1 Month Momentum %
-17.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
20.29
Quick Ratio
20.29
Cash Ratio
19.55
Days Sales Outstanding
240.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-0.9
Shareholder Yield %
0.14

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
65.41
Operating Margin %
-523891.89
Net Margin %
-407784.32
EBITDA Margin %
-347060
FCF Margin %
-421716.76
OCF Margin %
-382305.95
ROE %
-13.17
ROA %
-12.26
ROIC %
-87.76
3-Year ROIIC %
-24.33
ROC (Joel Greenblatt) %
-134.5
ROCE %
-12.67

Financials

ROCO:6976's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Acepodia Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$) 0.185
EPS (TTM) (NT$) -1.3
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 28.94
14-Day RSI 40.86
14-Day ATR (NT$) 0.475057
20-Day SMA (NT$) 13.05
12-1 Month Momentum % -17.2
52-Week Range (NT$) 10.85 - 19.15
Shares Outstanding (Mil) 582.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acepodia Inc Filings

Filing Date Document Date Form
No Filing Data

Acepodia Inc Stock Events

Financials Calendars
Event Date Price (NT$)
No Event Data

Acepodia Inc Frequently Asked Questions

What is Acepodia Inc(ROCO:6976)'s stock price today?
The current price of ROCO:6976 is NT$12.60. The 52 week high of ROCO:6976 is NT$19.15 and 52 week low is NT$10.85.
When is next earnings date of Acepodia Inc(ROCO:6976)?
The next earnings date of Acepodia Inc(ROCO:6976) is .
Does Acepodia Inc(ROCO:6976) pay dividends? If so, how much?
Acepodia Inc(ROCO:6976) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Acepodia Inc

No articles.